SunWay Biotech Co., LTD.
SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company offers red yeast rice and lactic acid bacteria products, as well as other health supplements; and wholesale and manufacturing of pharmaceutical products. The company also researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus… Read more
Market Cap & Net Worth: SunWay Biotech Co., LTD. (1271)
SunWay Biotech Co., LTD. (TWO:1271) has a market capitalization of $94.62 Million (NT$3.13 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #21683 globally and #1203 in its home market, demonstrating a -0.95% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SunWay Biotech Co., LTD.'s stock price NT$52.10 by its total outstanding shares 60088066 (60.09 Million).
SunWay Biotech Co., LTD. Market Cap History: 2026 to 2026
SunWay Biotech Co., LTD.'s market capitalization history from 2026 to 2026. Data shows growth from $94.62 Million to $94.62 Million (0.00% CAGR).
SunWay Biotech Co., LTD. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SunWay Biotech Co., LTD.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 1271 by Market Capitalization
Companies near SunWay Biotech Co., LTD. in the global market cap rankings as of March 19, 2026.
Key companies related to SunWay Biotech Co., LTD. by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #54 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #69 globally with a market cap of $218.85 Billion USD ( CHF200.39 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #435 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #465 globally with a market cap of $45.94 Billion USD ( €44.75 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #54 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #69 | Nestlé S.A. | SW:NESN | $218.85 Billion | CHF77.97 |
| #435 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #465 | Danone SA | PA:BN | $45.94 Billion | €70.78 |
SunWay Biotech Co., LTD. Historical Marketcap From 2026 to 2026
Between 2026 and today, SunWay Biotech Co., LTD.'s market cap moved from $94.62 Million to $ 94.62 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$94.62 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of SunWay Biotech Co., LTD. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $94.62 Million USD |
| MoneyControl | $94.62 Million USD |
| MarketWatch | $94.62 Million USD |
| marketcap.company | $94.62 Million USD |
| Reuters | $94.62 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.